Results 41 to 50 of about 280,167 (140)

A longitudinal study examining how self-injection social norms are associated with contraceptive self-injectable interest and use in rural Uganda [PDF]

BMC Women's Health
Background There is mounting evidence that social norms affect attitudes, decision-making, and behaviors related to contraceptive use. Integral to the self-care movement for women to have more control over their reproductive health, subcutaneous depot ...
Erica Sedlander, Nitya Turaga, Catherine Birabwa, Ronald Wasswa, Beth Phillips, Dinah Amongin, Sneha Challa, Sylvie Nano, Betty Kyobe, Agnes Kayego, Peter Waiswa, Kelsey Holt   +11 more
doaj   +2 more sources

Knowledge, confidence and social support: Kenyan women’s priority needs for contraceptive self-injection learning through a social cognitive theory lens [PDF]

BMC Women's Health
Background Self-injectable contraceptives provide individuals the opportunity to prevent pregnancy with a self-controlled method that helps enhance self-care.
Serah Gitome, Lauren Suchman, Sarah Okumu, Pauline Wekesa, Janelli Vallin, Louisa Ndunyu, Zachary A. Kwena, Jenny Liu, Kelsey Holt, Elizabeth A. Bukusi   +9 more
doaj   +2 more sources

Accessing DMPA-SC through the public and private sectors in Nigeria: users’ characteristics and their experiences [PDF]

Gates Open Research, 2019
Background: Beginning in 2015, subcutaneous depot medroxyprogesterone acetate (DMPA-SC) was added to the contraceptive method mix in Nigeria, primarily through social marketing in the private sector and community-based distribution in the public sector.
Jenny Liu, Jennifer Shen, Eric Schatzkin, Olanike Adedeji, Eugene J Kongnyuy, Chidinma Onuoha, Morenike Fajemisin, Kazeem Ayodeji, Elizabeth Omoluabi   +8 more
openalex   +2 more sources

Examining the relationship between reproductive empowerment and contraceptive self-injection: Tackling the endogeneity problem. [PDF]

PLoS ONE
BackgroundSelf-care interventions, including contraceptive self-injectables such as subcutaneous depot medroxyprogesterone acetate (DMPA-SC), are hypothesized to be empowering to users.
Megan M Lydon, Holly M Burke, Katherine M Anfinson, Tihut Mulugeta, Aderaw Anteneh, Teferi Teklu, Mario Chen   +6 more
doaj   +2 more sources

Assessing the barriers and enablers of on-the-job provider training for subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in the public sector in Ghana: a cross-sectional mixed-methods study [PDF]

medRxiv
Chelsey Porter Erlank, Mensimah Bentsi-Enchill, Samuel Nii Adu Tagoe, Joyce Ami Amedoe, Melinda A. Stanley, Claudette Ahliba Diogo, Kofi Issah   +6 more
openalex   +2 more sources

Society of Family Planning clinical consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).

Contraception, 2022
Depot medroxyprogesterone acetate (DMPA) is a highly-effective, injectable contraceptive method that requires injections every 12 to 15 weeks. The need for return visits to a healthcare provider may present barriers to access, use, and continuation of DMPA.
J. Kohn, Elise D. Berlan, Jennifer H Tang, A. Beasley   +3 more
semanticscholar   +3 more sources

Contraceptive efficacy and safety of DMPA-SC [PDF]

Journal of Family Planning and Reproductive Health Care, 2005
Judy Murty
openalex   +2 more sources

An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa. [PDF]

Contraception, 2018
Bertrand JT, Bidashimwa D, Makani PB, Hernandez JH, Akilimali P, Binanga A.   +5 more
europepmc   +2 more sources

Self-injected contraceptives: does the investment reflect women’s preferences?

BMJ Global Health, 2022
Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an innovative contraceptive method aimed at meeting women’s unique circumstances and needs, largely due to its ability to be self-injected.
Sophia Magalona, Pierre Akilimali, Philip Anglewicz, Peter Gichangi, Elizabeth Omoluabi, Funmilola OlaOlorun, Georges Guiella, Shannon N. Wood, Linnea A. Zimmerman   +8 more
doaj   +1 more source

Testing a counseling message for increasing uptake of self-injectable contraception in southern Malawi: A mixed-methods, clustered randomized controlled study

PLoS ONE, 2022
Objective While self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has well-documented benefits, uptake may be improved by addressing client concerns such as fear of self-injury and low self-efficacy.
Holly M. Burke, Catherine Packer, Akuzike Zingani, Philemon Moses, Alissa Bernholc, Lucy W. Ruderman, Andres Martinez, Mario Chen   +7 more
doaj   +2 more sources